Stocks

Aviva (LON:AV.) Full Year 2023 Results Key Financial Results Net income: UK£1.09b (up from UK£1.19b loss in FY 2022). earnings-and-revenue-growth All figures shown in the chart above are for the trailing 12 month (TTM) period Aviva Earnings Insights Looking ahead, revenue is forecast to …

Key Insights The considerable ownership by individual investors in LondonMetric Property indicates that they collectively have a greater say in management and business strategy 31% of the business is held by the top 25 shareholders 48% of LondonMetric Property is held by Institutions Every …

It's been a pretty great week for Oxford Nanopore Technologies plc (LON:ONT) shareholders, with its shares surging 11% to UK£1.44 in the week since its latest full-year results. Oxford Nanopore Technologies reported revenues of UK£170m, in line with expectations, but it unfortunately also reported …

Rotork (LON:ROR) Full Year 2023 Results Key Financial Results Revenue: UK£719.2m (up 12% from FY 2022). Net income: UK£113.1m (up 21% from FY 2022). Profit margin: 16% (up from 14% in FY 2022). The increase in margin was driven by higher revenue. EPS: UK£0.13 …

Net Sales: Increased to $270,065 thousand from $268,483 thousand in the prior year. Net Income: Rose to $39,592 thousand, up from $34,361 thousand year-over-year. Earnings Per Share (EPS): Improved to $0.42, both basic and diluted, compared to $0.37 in the previous year. Trailing Twelve …

Patients treated with BIMZELX® (bimekizumab-bkzx) demonstrated clinically meaningful improvements in skin pain up to 48 weeks, across various assessed outcomes At Week 16, patients treated with BIMZELX demonstrated greater draining tunnel reductions versus placebo that were sustained or improved to Week 48 Disease-associated pain …

Euronext Paris SA ContactsMedia Contact Investor Relations Amsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 17 Dublin +39 02 72 42 62 13 Lisbon +351 91 777 68 97 Milan +39 02 72 42 67 56 …